nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADORA2A—NGF-independant TRKA activation—NTRK2—peripheral nervous system neoplasm	0.0203	0.0877	CbGpPWpGaD
Adenosine—ADORA2A—Activation of TRKA receptors—NTRK2—peripheral nervous system neoplasm	0.0175	0.0758	CbGpPWpGaD
Adenosine—Tenofovir—NME1—peripheral nervous system neoplasm	0.017	0.642	CrCbGaD
Adenosine—ADORA2A—NGF-independant TRKA activation—NTRK1—peripheral nervous system neoplasm	0.0166	0.0715	CbGpPWpGaD
Adenosine—ADORA2A—Activation of TRKA receptors—NTRK1—peripheral nervous system neoplasm	0.0143	0.0618	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0121	0.0521	CbGpPWpGaD
Adenosine—ADK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0105	0.0456	CbGpPWpGaD
Adenosine—ADA—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00716	0.031	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00512	0.0221	CbGpPWpGaD
Adenosine—Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.00495	0.187	CrCbGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00448	0.0193	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.00428	0.0185	CbGpPWpGaD
Adenosine—ADORA2A—Monoamine Transport—TH—peripheral nervous system neoplasm	0.00421	0.0182	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00407	0.0176	CbGpPWpGaD
Adenosine—Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.00386	0.146	CrCbGaD
Adenosine—ADORA2A—ganglion—peripheral nervous system neoplasm	0.00347	0.171	CbGeAlD
Adenosine—ADORA2B—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00342	0.0148	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—NTRK1—peripheral nervous system neoplasm	0.00317	0.0137	CbGpPWpGaD
Adenosine—ADORA1—nerve—peripheral nervous system neoplasm	0.00303	0.149	CbGeAlD
Adenosine—ADORA1—ganglion—peripheral nervous system neoplasm	0.003	0.147	CbGeAlD
Adenosine—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.00253	0.0109	CbGpPWpGaD
Adenosine—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—peripheral nervous system neoplasm	0.00226	0.00978	CbGpPWpGaD
Adenosine—ADORA2A—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00224	0.0097	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00215	0.0093	CbGpPWpGaD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00205	0.00886	CbGpPWpGaD
Adenosine—ADORA2B—trigeminal ganglion—peripheral nervous system neoplasm	0.00205	0.101	CbGeAlD
Adenosine—ADK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00205	0.00884	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00197	0.0085	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00183	0.0079	CbGpPWpGaD
Adenosine—ADORA2B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00177	0.00766	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00169	0.00729	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00164	0.00708	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00159	0.00687	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00157	0.00679	CbGpPWpGaD
Adenosine—ADK—trigeminal ganglion—peripheral nervous system neoplasm	0.00153	0.0752	CbGeAlD
Adenosine—ADA—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.0015	0.00649	CbGpPWpGaD
Adenosine—ADORA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00147	0.0723	CbGeAlD
Adenosine—ADK—parotid gland—peripheral nervous system neoplasm	0.00144	0.071	CbGeAlD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00141	0.0061	CbGpPWpGaD
Adenosine—DPP4—parotid gland—peripheral nervous system neoplasm	0.0014	0.0688	CbGeAlD
Adenosine—ADORA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00139	0.00602	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00139	0.00601	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00139	0.00601	CbGpPWpGaD
Adenosine—ADK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00138	0.00597	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00134	0.00577	CbGpPWpGaD
Adenosine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00177	CcSEcCtD
Adenosine—Back pain—Vincristine—peripheral nervous system neoplasm	0.00127	0.00176	CcSEcCtD
Adenosine—Pain—Topotecan—peripheral nervous system neoplasm	0.00126	0.00175	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00175	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00125	0.00542	CbGpPWpGaD
Adenosine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00174	CcSEcCtD
Adenosine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00174	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00174	CcSEcCtD
Adenosine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00173	CcSEcCtD
Adenosine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00172	CcSEcCtD
Adenosine—Pain—Melphalan—peripheral nervous system neoplasm	0.00124	0.00172	CcSEcCtD
Adenosine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00171	CcSEcCtD
Adenosine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00171	CcSEcCtD
Adenosine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00171	CcSEcCtD
Adenosine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00169	CcSEcCtD
Adenosine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00122	0.00168	CcSEcCtD
Adenosine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00121	0.00167	CcSEcCtD
Adenosine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00167	CcSEcCtD
Adenosine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00166	CcSEcCtD
Adenosine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00166	CcSEcCtD
Adenosine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00165	CcSEcCtD
Adenosine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00165	CcSEcCtD
Adenosine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00164	CcSEcCtD
Adenosine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00163	CcSEcCtD
Adenosine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00117	0.00163	CcSEcCtD
Adenosine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00161	CcSEcCtD
Adenosine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00161	CcSEcCtD
Adenosine—ADORA2A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00116	0.00503	CbGpPWpGaD
Adenosine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00161	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.00116	0.005	CbGpPWpGaD
Adenosine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.0016	CcSEcCtD
Adenosine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00115	0.00159	CcSEcCtD
Adenosine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00159	CcSEcCtD
Adenosine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00114	0.00158	CcSEcCtD
Adenosine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00157	CcSEcCtD
Adenosine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00113	0.00157	CcSEcCtD
Adenosine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00113	0.00157	CcSEcCtD
Adenosine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00113	0.00157	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—MYC—peripheral nervous system neoplasm	0.00113	0.00489	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00112	0.00482	CbGpPWpGaD
Adenosine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00154	CcSEcCtD
Adenosine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.0011	0.00153	CcSEcCtD
Adenosine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00152	CcSEcCtD
Adenosine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00152	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00151	CcSEcCtD
Adenosine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00109	0.00151	CcSEcCtD
Adenosine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00151	CcSEcCtD
Adenosine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.0015	CcSEcCtD
Adenosine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.0015	CcSEcCtD
Adenosine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00108	0.0015	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.00108	0.00465	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00108	0.00465	CbGpPWpGaD
Adenosine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00149	CcSEcCtD
Adenosine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00107	0.00148	CcSEcCtD
Adenosine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00107	0.00148	CcSEcCtD
Adenosine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00106	0.00147	CcSEcCtD
Adenosine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00146	CcSEcCtD
Adenosine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00146	CcSEcCtD
Adenosine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00104	0.00144	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00104	0.0045	CbGpPWpGaD
Adenosine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00104	0.00144	CcSEcCtD
Adenosine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00144	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—peripheral nervous system neoplasm	0.00104	0.00448	CbGpPWpGaD
Adenosine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00104	0.00143	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00103	0.00447	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00103	0.00446	CbGpPWpGaD
Adenosine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00103	0.00143	CcSEcCtD
Adenosine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00142	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00141	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.0014	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.00101	0.00437	CbGpPWpGaD
Adenosine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.00101	0.0014	CcSEcCtD
Adenosine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00139	CcSEcCtD
Adenosine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.001	0.00139	CcSEcCtD
Adenosine—ADK—Metabolism—GNS—peripheral nervous system neoplasm	0.000999	0.00432	CbGpPWpGaD
Adenosine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000998	0.00138	CcSEcCtD
Adenosine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000991	0.00137	CcSEcCtD
Adenosine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000988	0.00137	CcSEcCtD
Adenosine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000985	0.00136	CcSEcCtD
Adenosine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000978	0.00135	CcSEcCtD
Adenosine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000976	0.00135	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000976	0.00135	CcSEcCtD
Adenosine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000974	0.00135	CcSEcCtD
Adenosine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00097	0.00134	CcSEcCtD
Adenosine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00097	0.00134	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000969	0.00419	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000967	0.00418	CbGpPWpGaD
Adenosine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000962	0.00133	CcSEcCtD
Adenosine—ADK—Metabolism—NME1—peripheral nervous system neoplasm	0.000958	0.00414	CbGpPWpGaD
Adenosine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.00132	CcSEcCtD
Adenosine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000947	0.00131	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000942	0.00407	CbGpPWpGaD
Adenosine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000941	0.0013	CcSEcCtD
Adenosine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00094	0.0013	CcSEcCtD
Adenosine—ADA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000939	0.00406	CbGpPWpGaD
Adenosine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000938	0.0013	CcSEcCtD
Adenosine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000938	0.0013	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000935	0.00129	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000935	0.00129	CcSEcCtD
Adenosine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000933	0.00129	CcSEcCtD
Adenosine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000933	0.00129	CcSEcCtD
Adenosine—Rash—Topotecan—peripheral nervous system neoplasm	0.000932	0.00129	CcSEcCtD
Adenosine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000932	0.00129	CcSEcCtD
Adenosine—Cough—Etoposide—peripheral nervous system neoplasm	0.000928	0.00129	CcSEcCtD
Adenosine—Headache—Topotecan—peripheral nervous system neoplasm	0.000926	0.00128	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000926	0.004	CbGpPWpGaD
Adenosine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000925	0.00128	CcSEcCtD
Adenosine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000925	0.00128	CcSEcCtD
Adenosine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000925	0.00128	CcSEcCtD
Adenosine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000924	0.00128	CcSEcCtD
Adenosine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000924	0.00128	CcSEcCtD
Adenosine—ADK—Metabolism—COX2—peripheral nervous system neoplasm	0.000922	0.00398	CbGpPWpGaD
Adenosine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000921	0.00128	CcSEcCtD
Adenosine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000921	0.00128	CcSEcCtD
Adenosine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000919	0.00127	CcSEcCtD
Adenosine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000919	0.00127	CcSEcCtD
Adenosine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000918	0.00127	CcSEcCtD
Adenosine—Pain—Vincristine—peripheral nervous system neoplasm	0.000916	0.00127	CcSEcCtD
Adenosine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000916	0.00127	CcSEcCtD
Adenosine—Rash—Melphalan—peripheral nervous system neoplasm	0.000913	0.00126	CcSEcCtD
Adenosine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000912	0.00126	CcSEcCtD
Adenosine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000905	0.00125	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000904	0.00391	CbGpPWpGaD
Adenosine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000901	0.00125	CcSEcCtD
Adenosine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000894	0.00124	CcSEcCtD
Adenosine—ADORA2B—cerebellum—peripheral nervous system neoplasm	0.000894	0.0439	CbGeAlD
Adenosine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000885	0.00123	CcSEcCtD
Adenosine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000883	0.00122	CcSEcCtD
Adenosine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000883	0.00122	CcSEcCtD
Adenosine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000878	0.00122	CcSEcCtD
Adenosine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00121	CcSEcCtD
Adenosine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00121	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.00121	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000868	0.0012	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000868	0.0012	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000863	0.0012	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000862	0.00372	CbGpPWpGaD
Adenosine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00086	0.00119	CcSEcCtD
Adenosine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00086	0.00119	CcSEcCtD
Adenosine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000851	0.00118	CcSEcCtD
Adenosine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000847	0.00117	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000846	0.00366	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—peripheral nervous system neoplasm	0.000845	0.00365	CbGpPWpGaD
Adenosine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000845	0.00117	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000841	0.00363	CbGpPWpGaD
Adenosine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000839	0.00116	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000838	0.00362	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000822	0.00355	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000822	0.00355	CbGpPWpGaD
Adenosine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.00113	CcSEcCtD
Adenosine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000811	0.00112	CcSEcCtD
Adenosine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00081	0.00112	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000809	0.00349	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000806	0.00348	CbGpPWpGaD
Adenosine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000798	0.00111	CcSEcCtD
Adenosine—ADORA2A—Signaling by NGF—NTRK2—peripheral nervous system neoplasm	0.000797	0.00345	CbGpPWpGaD
Adenosine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00109	CcSEcCtD
Adenosine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000789	0.00109	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000787	0.0034	CbGpPWpGaD
Adenosine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000779	0.00108	CcSEcCtD
Adenosine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000774	0.00107	CcSEcCtD
Adenosine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000772	0.00107	CcSEcCtD
Adenosine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000769	0.00106	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000763	0.00106	CcSEcCtD
Adenosine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000762	0.00106	CcSEcCtD
Adenosine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000756	0.00105	CcSEcCtD
Adenosine—ADORA2A—cerebellum—peripheral nervous system neoplasm	0.000744	0.0366	CbGeAlD
Adenosine—Pain—Etoposide—peripheral nervous system neoplasm	0.000742	0.00103	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.00074	0.0032	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000736	0.00318	CbGpPWpGaD
Adenosine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.00102	CcSEcCtD
Adenosine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000731	0.00101	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.00101	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000715	0.00309	CbGpPWpGaD
Adenosine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.000987	CcSEcCtD
Adenosine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000708	0.000982	CcSEcCtD
Adenosine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000707	0.000979	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000706	0.000978	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000702	0.00303	CbGpPWpGaD
Adenosine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000701	0.000971	CcSEcCtD
Adenosine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0007	0.00097	CcSEcCtD
Adenosine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000698	0.000967	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000697	0.000966	CcSEcCtD
Adenosine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000697	0.000965	CcSEcCtD
Adenosine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000689	0.000955	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000685	0.00296	CbGpPWpGaD
Adenosine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000944	CcSEcCtD
Adenosine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000681	0.000944	CcSEcCtD
Adenosine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00068	0.000942	CcSEcCtD
Adenosine—ADA—Metabolism—GNS—peripheral nervous system neoplasm	0.000679	0.00293	CbGpPWpGaD
Adenosine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000677	0.000937	CcSEcCtD
Adenosine—Rash—Vincristine—peripheral nervous system neoplasm	0.000676	0.000936	CcSEcCtD
Adenosine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000675	0.000935	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	0.000674	0.0255	CrCbGaD
Adenosine—Headache—Vincristine—peripheral nervous system neoplasm	0.000671	0.00093	CcSEcCtD
Adenosine—ADK—cerebellum—peripheral nervous system neoplasm	0.000668	0.0328	CbGeAlD
Adenosine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.000915	CcSEcCtD
Adenosine—ADA—Metabolism—NME1—peripheral nervous system neoplasm	0.000651	0.00281	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NTRK1—peripheral nervous system neoplasm	0.00065	0.00281	CbGpPWpGaD
Adenosine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.000894	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000644	0.00278	CbGpPWpGaD
Adenosine—ADORA1—cerebellum—peripheral nervous system neoplasm	0.000642	0.0316	CbGeAlD
Adenosine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000639	0.000886	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000885	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000637	0.00275	CbGpPWpGaD
Adenosine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000636	0.000882	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00088	CcSEcCtD
Adenosine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00088	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000635	0.00274	CbGpPWpGaD
Adenosine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00063	0.000873	CcSEcCtD
Adenosine—ADA—Metabolism—COX2—peripheral nervous system neoplasm	0.000627	0.00271	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000626	0.0027	CbGpPWpGaD
Adenosine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000623	0.000863	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000855	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000612	0.000847	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000608	0.00263	CbGpPWpGaD
Adenosine—ADK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000605	0.00261	CbGpPWpGaD
Adenosine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000602	0.000834	CcSEcCtD
Adenosine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000828	CcSEcCtD
Adenosine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000827	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000597	0.00258	CbGpPWpGaD
Adenosine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000818	CcSEcCtD
Adenosine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000815	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000815	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000588	0.00254	CbGpPWpGaD
Adenosine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00081	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000809	CcSEcCtD
Adenosine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000802	CcSEcCtD
Adenosine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000799	CcSEcCtD
Adenosine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000574	0.000795	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000791	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000784	CcSEcCtD
Adenosine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000563	0.00078	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000778	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000552	0.00239	CbGpPWpGaD
Adenosine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000552	0.000765	CcSEcCtD
Adenosine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000548	0.000759	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000547	0.00237	CbGpPWpGaD
Adenosine—Rash—Etoposide—peripheral nervous system neoplasm	0.000547	0.000758	CcSEcCtD
Adenosine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000547	0.000757	CcSEcCtD
Adenosine—Headache—Etoposide—peripheral nervous system neoplasm	0.000544	0.000753	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000542	0.00234	CbGpPWpGaD
Adenosine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.00075	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.000748	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTPN11—peripheral nervous system neoplasm	0.000539	0.00233	CbGpPWpGaD
Adenosine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000742	CcSEcCtD
Adenosine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000741	CcSEcCtD
Adenosine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000739	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000529	0.00229	CbGpPWpGaD
Adenosine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000527	0.00073	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000726	CcSEcCtD
Adenosine—Cough—Epirubicin—peripheral nervous system neoplasm	0.00052	0.000721	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00072	CcSEcCtD
Adenosine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000716	CcSEcCtD
Adenosine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000516	0.000714	CcSEcCtD
Adenosine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000713	CcSEcCtD
Adenosine—ADK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000511	0.00221	CbGpPWpGaD
Adenosine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000703	CcSEcCtD
Adenosine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000702	CcSEcCtD
Adenosine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000701	CcSEcCtD
Adenosine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000695	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.0005	0.00216	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000497	0.00215	CbGpPWpGaD
Adenosine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000688	CcSEcCtD
Adenosine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000685	CcSEcCtD
Adenosine—ADK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000488	0.00211	CbGpPWpGaD
Adenosine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000675	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000674	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000672	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000483	0.00209	CbGpPWpGaD
Adenosine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000667	CcSEcCtD
Adenosine—ADK—Metabolism—TH—peripheral nervous system neoplasm	0.000481	0.00208	CbGpPWpGaD
Adenosine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000663	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000662	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.00066	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000476	0.00206	CbGpPWpGaD
Adenosine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000658	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00047	0.000652	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000651	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000648	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000643	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000461	0.00199	CbGpPWpGaD
Adenosine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000636	CcSEcCtD
Adenosine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000455	0.00063	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000624	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000614	CcSEcCtD
Adenosine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000614	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.00044	0.0019	CbGpPWpGaD
Adenosine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000609	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000605	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000603	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000601	CcSEcCtD
Adenosine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000599	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.000426	0.00184	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000423	0.00183	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000422	0.00182	CbGpPWpGaD
Adenosine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000583	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000418	0.00181	CbGpPWpGaD
Adenosine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000576	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000416	0.0018	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000414	0.00179	CbGpPWpGaD
Adenosine—ADA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000411	0.00178	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000568	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000405	0.00175	CbGpPWpGaD
Adenosine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00056	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000556	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000554	CcSEcCtD
Adenosine—ADK—Metabolism—GNAS—peripheral nervous system neoplasm	0.000392	0.0017	CbGpPWpGaD
Adenosine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000535	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000386	0.00167	CbGpPWpGaD
Adenosine—ADK—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000385	0.00166	CbGpPWpGaD
Adenosine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000533	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000378	0.00163	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000376	0.00163	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000364	0.00157	CbGpPWpGaD
Adenosine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000497	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000495	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000354	0.00153	CbGpPWpGaD
Adenosine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000484	CcSEcCtD
Adenosine—ADA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000348	0.0015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000347	0.0015	CbGpPWpGaD
Adenosine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000459	CcSEcCtD
Adenosine—ADA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000332	0.00143	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00033	0.00143	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000328	0.00142	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000327	0.00141	CbGpPWpGaD
Adenosine—ADA—Metabolism—TH—peripheral nervous system neoplasm	0.000327	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000326	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000324	0.0014	CbGpPWpGaD
Adenosine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000447	CcSEcCtD
Adenosine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000446	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000321	0.00139	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00032	0.00138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000313	0.00135	CbGpPWpGaD
Adenosine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000429	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000309	0.00134	CbGpPWpGaD
Adenosine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000425	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000425	CcSEcCtD
Adenosine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000422	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000412	CcSEcCtD
Adenosine—ADORA2A—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000297	0.00128	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000295	0.00128	CbGpPWpGaD
Adenosine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000289	0.0004	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000397	CcSEcCtD
Adenosine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000393	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000393	CcSEcCtD
Adenosine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000391	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000281	0.00121	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000273	0.00118	CbGpPWpGaD
Adenosine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00037	CcSEcCtD
Adenosine—ADA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000267	0.00115	CbGpPWpGaD
Adenosine—ADA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000262	0.00113	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000261	0.00113	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000253	0.00109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000249	0.00108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000248	0.00107	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000247	0.00107	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000239	0.00103	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000237	0.00102	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00023	0.000992	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000228	0.000985	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000223	0.000964	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000222	0.000959	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000217	0.000937	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000213	0.000919	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000209	0.000905	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000195	0.000844	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000195	0.000843	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00019	0.00082	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000182	0.000788	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000181	0.000781	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000171	0.00074	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000166	0.000717	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000161	0.000696	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000151	0.000651	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000146	0.000633	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00014	0.000603	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000138	0.000597	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000136	0.000586	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000128	0.000554	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000117	0.000507	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000115	0.000498	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000107	0.000463	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—peripheral nervous system neoplasm	0.000106	0.000458	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000101	0.000436	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.82e-05	0.000424	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.73e-05	0.00042	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.11e-05	0.000394	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.06e-05	0.000392	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.92e-05	0.000385	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.9e-05	0.000385	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.59e-05	0.000371	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.35e-05	0.000361	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.27e-05	0.000357	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.15e-05	0.000352	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.59e-05	0.000328	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.58e-05	0.000328	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—peripheral nervous system neoplasm	7.2e-05	0.000311	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.04e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.93e-05	0.0003	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.63e-05	0.000286	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.46e-05	0.000279	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.45e-05	0.000279	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.39e-05	0.000276	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.24e-05	0.00027	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.97e-05	0.000258	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.85e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.35e-05	0.000231	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.3e-05	0.000229	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.27e-05	0.000228	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.07e-05	0.000219	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.99e-05	0.000215	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.48e-05	0.000194	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.09e-05	0.000177	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.92e-05	0.000169	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.46e-05	0.000149	CbGpPWpGaD
